Bicuspid/Mitral Open-Heart Surgery Quality of Life 
DAIC
JUNE 21, 2024
The EVOQUE tricuspid valve replacement system is a device designed to treat patients with severe leaking of the tricuspid valve, known as tricuspid regurgitation, without open heart surgery. The EVOQUE valve is implanted using a minimally invasive delivery system (a catheter) through the femoral vein reaching to the heart.
DAIC
JANUARY 4, 2024
These key takeaways from the research letter on IVL-facilitated valvuloplasty for severely calcified mitral valve stenosis are published in the Journal of the American College of Cardiology (JACC) Cardiovascular Interventions. an interventional cardiologist and structural heart disease expert at Henry Ford Health. “We
DAIC
JUNE 10, 2024
milla1cf Mon, 06/10/2024 - 17:58 June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial tricuspid clip procedure in the Carolinas, performed in May at Atrium Health Carolinas Medical Center. This procedure has since become a cornerstone in the field of structural heart interventions.
DAIC
FEBRUARY 15, 2024
Tricuspid regurgitation can put added strain on the heart and lead to other cardiovascular issues, which can significantly worsen a person's quality of life, but historically there have been few treatment options," said Lars Søndergaard , M.D.,
DAIC
APRIL 2, 2024
Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 are affected by tricuspid regurgitation, 1 which can severely impact quality of life. Abbott has announced U.S million people in the U.S. are estimated to be affected. and Lynn C.
Expert insights. Personalized for you.
105 
Let's personalize your content